Biography
Videos
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of California | Diversity, Equity, and Inclusion Champion Training | 12/2020 | |
Stanford University | M.D. | School of Medicine | 1990 |
Board Certifications
American Board of Surgery, 1996
Collaboration Interests
I am interested in:
- PhysicianScientist
Clinical Expertise
Expanded Criteria Donor Kidney Transplantation
Immunosuppression for Liver Transplantation
Kidney Transplantation
Liver Transplantation
MELD Allocation and Living Donor Liver Transplantation
Pancreas Transplantation
Clinical Trials
- Liver Transplantation With Tregs at UCSF (NCT03654040)Related Conditions: Liver Transplant| Start Date: | End Date:
- Related Conditions: Liver Disease, Liver Transplant| Start Date: | End Date:
- Related Conditions: Liver Transplant| Start Date: | End Date:
- Related Conditions: Liver Transplant| Start Date: | End Date:
- Related Conditions: Liver Transplant| Start Date: | End Date:
Program Affiliations
- Clinical Fellowship, Division of Transplantation
- The Liver Center at UCSF
- Director, Expanded Criteria Donor Kidney Transplant Program, University of California, San Francisco
- UCSF Hellen Diller Family Comprehensive Cancer Center
In the News
Grants and Funding
- PROSPECTIVE LONGITUDINAL STUDY OF IWITH SCREEN FAILURES SECONDARY TO HISTOPATHOLOGY | NIH | 2017-08-10 - 2021-07-31 | Role: Principal Investigator
- Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation | NIH | 2014-06-01 - 2021-05-31 | Role: Principal Investigator
- Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients | NIH | 2013-02-01 - 2020-01-31 | Role: Principal Investigator
- Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients | NIH | 2012-07-27 - 2019-06-30 | Role: Principal Investigator
- Donor-Specific Regulatory T Cell Therapy in Liver Transplantation | NIH | 2012-04-01 - 2014-03-31 | Role: Principal Investigator
- Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients | NIH | 2009-09-30 - 2013-03-31 | Role: Principal Investigator
Dr. Feng's research interest focuses on transplant immunology, with a particular focus on determinants of organ tolerance. She is also investigating novel immunosuppressive regimens and pursuing immunosuppression withdrawal in selected liver transplant recipients. By studying the immune profiles of transplant patients who are successfully weaned from immunosuppressants, she and her group hope to predict prospectively which patients may be good candidates for immunosuppression withdrawal.
Research Interests
- Immunosuppression Withdrawal for Stable Pediatric Living Donor Liver Transplant Recipients
- Immunosuppression Withdrawal and Identification of a Profile Predictive of Tolerance
- Defining the Optimal Immunosuppression for Specific Transplant Settings
- Expanded Criteria Donors
- Novel Immunosuppression Strategies for Liver Transplantation
- Strategies to Decrease Ischemia Reperfusion Injury to Improve Early Graft Function after Kidney Transplantation
- Improving Long-term Outcomes for Liver Transplant Recipients
Publications
- Transforming the Future of Surgeon-Scientists.| | View in PubMed
- Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis.| | View in PubMed
- Kidney transplantation in a patient with anomalous iliofemoral vasculature.| | View in PubMed
- DCD liver transplant in patients with a MELD over 35.| | View in PubMed
- Mapping children by ALT 4-5 years after liver transplant: Potential individual and population applications.| | View in PubMed
- Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights.| | View in PubMed
- Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States: A Randomized Controlled Trial.| | View in PubMed
- Real-world implementation of normothermic machine perfusion: A detailed analysis of intraoperative and early postoperative impact.| | View in PubMed
- Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation.| | View in PubMed
- Supporting Robust Teamwork - Bridging Technology and Organizational Science.| | View in PubMed
- Immunosuppression after pediatric liver transplant: The parents' perspective.| | View in PubMed
- Addressing sex-based disparities in solid organ transplantation in the United States - a conference report.| | View in PubMed
- Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans.| | View in PubMed
- Next-generation pathology detection of T cell-antigen-presenting cell immune synapses in human liver allografts.| | View in PubMed
- Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients.| | View in PubMed
- Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.| | View in PubMed
- Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies.| | View in PubMed
- We Asked the Experts: Toward Personalized Immunosuppression for Liver Transplant Recipients.| | View in PubMed
- Not everything that counts can be counted: Tracking long-term outcomes in pediatric liver transplant recipients.| | View in PubMed
- Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.| | View in PubMed
- Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.| | View in PubMed
- Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.| | View in PubMed
- The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study.| | View in PubMed
- Baby Steps: Understanding Allograft Fibrosis in Pediatric Liver Transplantation.| | View in PubMed
- Non-invasive alloimmune risk stratification of long-term liver transplant recipients.| | View in PubMed
- Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.| | View in PubMed
- Improvements in Disease-Specific Health-Related Quality of Life of Pediatric Liver Transplant Recipients During Immunosuppression Withdrawal.| | View in PubMed
- Transplantation From Older Donors: Can Senolytics Turn Back the Clock?| | View in PubMed
- COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.| | View in PubMed
- A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.| | View in PubMed
- Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.| | View in PubMed
- Rapid Modification of Workflows and Fellow Staffing at a Single Transplant Center to Address the COVID-19 Crisis.| | View in PubMed
- Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group.| | View in PubMed
- The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study.| | View in PubMed
- Long-term follow-up of beta cell replacement therapy in 10 HIV-infected patients with renal failure secondary to type 1 diabetes mellitus.| | View in PubMed
- IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients.| | View in PubMed
- Prevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients.| | View in PubMed
- Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.| | View in PubMed
- Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.| | View in PubMed
- Reply.| | View in PubMed
- Liver transplants for noncitizens/nonresidents: What is the problem, and what should be done?| | View in PubMed
- Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.| | View in PubMed
- Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.| | View in PubMed
- Reply.| | View in PubMed
- Physical frailty after liver transplantation.| | View in PubMed
- The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.| | View in PubMed
- Tolerance after liver transplantation: Where are we?| | View in PubMed
- Tolerance in clinical liver transplantation.| | View in PubMed
- Living donor liver transplantation in high Model for End-Stage Liver Disease score patients.| | View in PubMed
- Early and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation: Summary of an ESPGHAN Monothematic Conference.| | View in PubMed
- Development of a novel frailty index to predict mortality in patients with end-stage liver disease.| | View in PubMed
- Optimizing Graft Survival by Pretreatment of the Donor.| | View in PubMed
- Current status of tolerance in kidney transplantation.| | View in PubMed
- The questions not the answers: Outcomes after pediatric liver transplantation.| | View in PubMed
- A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.| | View in PubMed
- Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.| | View in PubMed
- Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation.| | View in PubMed
- Spontaneous and induced tolerance for liver transplant recipients.| | View in PubMed
- Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.| | View in PubMed
- Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.| | View in PubMed
- Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.| | View in PubMed
- The corrected donor age for hepatitis C virus-infected liver transplant recipients.| | View in PubMed
- Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.| | View in PubMed
- Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction.| | View in PubMed
- Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes.| | View in PubMed
- Expanded criteria donors.| | View in PubMed
- Multiple listings as a reflection of geographic disparity in liver transplantation.| | View in PubMed
- Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.| | View in PubMed
- Donor Risk Index for African American liver transplant recipients with hepatitis C virus.| | View in PubMed
- Peri-operative hyperglycemia is associated with delayed graft function in deceased donor renal transplantation.| | View in PubMed
- Offer patterns of nationally placed livers by donation service area.| | View in PubMed
- An examination of liver offers to candidates on the liver transplant wait-list.| | View in PubMed
- Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.| | View in PubMed
- Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.| | View in PubMed
- KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies.| | View in PubMed
- Kidney transplant performed after liver transplant: a single center experience.| | View in PubMed
- Preface: Optimization of outcomes for children after solid organ transplantation.| | View in PubMed
- Tolerance: is it achievable in pediatric solid organ transplantation?| | View in PubMed
- Management of the liver transplant patient.| | View in PubMed
- Factors influencing liver transplant length of stay at two large-volume transplant centers.| | View in PubMed
- Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation.| | View in PubMed
- Increased donor risk: who should bear the burden?| | View in PubMed
- Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.| | View in PubMed
- Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?| | View in PubMed
- Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.| | View in PubMed
- Steatotic livers for liver transplantation--life-saving but at a cost.| | View in PubMed
- Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?| | View in PubMed
- Linking the US transplant registry to administrative claims data: expanding the potential of transplant research.| | View in PubMed
- Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy.| | View in PubMed
- In a MELD-based economy, how can we fight off inflation?| | View in PubMed
- Optimizing living donor kidney graft function by donor-recipient pair selection.| | View in PubMed
- Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis?| | View in PubMed
- How can we define expanded criteria for liver donors?| | View in PubMed
- Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.| | View in PubMed
- Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice.| | View in PubMed
- Trends over a decade of pediatric liver transplantation in the United States.| | View in PubMed
- A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.| | View in PubMed
- End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation.| | View in PubMed
- Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center.| | View in PubMed
- Selecting livers for transplantation: can beggars be choosers?| | View in PubMed
- PELD: working well, but only half of the time?| | View in PubMed
- Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient.| | View in PubMed
- Impact of sirolimus on early graft function after deceased-donor kidney transplantation.| | View in PubMed
- An older liver in the hand, or a (possibly) younger liver in the bush?| | View in PubMed
- Surgical challenges in transplantation: the Fourth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium.| | View in PubMed
- BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.| | View in PubMed
- Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.| | View in PubMed
- Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival.| | View in PubMed
- Developmental context determines latency of MYC-induced tumorigenesis.| | View in PubMed
- Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens.| | View in PubMed
- Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.| | View in PubMed
- National conference to assess antibody-mediated rejection in solid organ transplantation.| | View in PubMed
- Early graft function after living donor kidney transplantation predicts rejection but not outcomes.| | View in PubMed
- An uncomfortable silence em leader while we all search for a better reporter gene in adult stem cell biology.| | View in PubMed
- Organ donors with malignant gliomas: an update.| | View in PubMed
- Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury.| | View in PubMed
- Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium.| | View in PubMed
- Death from donor-transmitted malignancy despite emergency liver retransplantation.| | View in PubMed
- Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.| | View in PubMed
- Management of lymphoceles after renal transplantation: laparoscopic versus open drainage.| | View in PubMed
- Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation.| | View in PubMed
- Expanded criteria donors for kidney transplantation.| | View in PubMed
- Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation.| | View in PubMed
- Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor.| | View in PubMed
- Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts.| | View in PubMed
- HIV-1 tat trans-activation requires the loop sequence within tar.| | View in PubMed